awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41825773-AD88ACF4-C75E-4E22-A31D-84142492F9CF
Q41825773-AD88ACF4-C75E-4E22-A31D-84142492F9CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41825773-AD88ACF4-C75E-4E22-A31D-84142492F9CF
Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.
P2860
Q41825773-AD88ACF4-C75E-4E22-A31D-84142492F9CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41825773-AD88ACF4-C75E-4E22-A31D-84142492F9CF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9e0c8c5559ca96d071d879d4494e94723534f493
P2860
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer.